Ilya Pharma

About:

Ilya Pharma develops the next-generation biological drugs for treating wounds in skin and mucosa.

Website: http://www.ilyapharma.se/

Twitter/X: ilyapharma

Top Investors: European Innovation Council, EASME - EU Executive Agency for SMEs, EIT Health

Description:

Ilya Pharma is a company that plans to solve the problem through a technique that makes the wounds heal faster. Ilya Pharma develops next-generation biological drugs for treating wounds in skin and mucosa. The company's business is to genetically rebuild lactic acid bacteria, such as those found in yogurt, so that they produce a bodily substance that speeds up the skin's healing. Ilya Pharma, founded 2016, is a spin-out pharmaceutical company and the innovation stems from many years of scientific reasearch at Uppsala University and the Swedish University of Agriculture.

Total Funding Amount:

$13.6M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Uppsala, Uppsala Lan, Sweden

Founded Date:

2016-01-01

Contact Email:

info(AT)ilyapharma.se

Founders:

Evelina Vågesjö, Göran Beijer, Mia Phillipson, Stefan Roos

Number of Employees:

11-50

Last Funding Date:

2020-07-09

IPO Status:

Private

Industries:

© 2025 bioDAO.ai